Buy Dr. Lal Pathlabs, target price Rs 2981: ICICI Securities

Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 16941.69 Crore) operating in Hospitals & Allied Services sector.

BCCL
Promoters held 55.23 per cent stake in the company as of 31-Mar-2022, while FIIs owned 23.44 per cent, DIIs 6.83 per cent.
ICICI Securities has buy call on Dr. Lal Pathlabs with a target price of Rs 2981. The current market price of Dr. Lal Pathlabs Ltd. is Rs 2040. Time period given by analyst is one year when Dr. Lal Pathlabs Ltd. price can reach defined target.

Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 16941.69 Crore) operating in Hospitals & Allied Services sector.

Dr. Lal Pathlabs Ltd. key Products/Revenue Segments include Hospital Services and Other Operating Revenue for the year ending 31-Mar-2021.



Financials
For the quarter ended 31-03-2022, the company reported a Consolidated Total Income of Rs 497.50 Crore, down -2.26 % from last quarter Total Income of Rs 509.00 Crore and up 11.92 % from last year same quarter Total Income of Rs 444.50 Crore. Company reported net profit after tax of Rs 62.10 Crore in latest quarter.


ADVERTISEMENT
Promoter/FII Holdings
Promoters held 55.23 per cent stake in the company as of 31-Mar-2022, while FIIs owned 23.44 per cent, DIIs 6.83 per cent.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Dr. Lal Pathlabs, target price Rs 2981: ICICI Securities
Text Size:AAA
Success
This article has been saved

*

+